C4 Therapeutics, Inc. Common Stock (NASDAQ: CCCC) last traded at $4.00, down 0.74% on the session. The quote above updates while this page is open; the figures below are drawn from C4 Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
C4 Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker CCCC. Its market capitalisation is $492.10 million.
Valuation measures for C4 Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $492.10M |
|---|---|
| Enterprise value | $525.63M |
| Price / sales | 14.04 |
| Price / book | 1.99 |
| Beta | 2.05 |
Trailing-twelve-month figures tagged in C4 Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $35.04M |
|---|---|
| Net income (TTM) | -$101.42M |
| EPS (TTM) | -$0.910 |
| Operating margin | -318.97% |
| Return on equity | -41.02% |
| Cash | $78.61M |
Range and volume for CCCC over the past 52 weeks.
| 52-week high | $5.17 |
|---|---|
| 52-week low | $1.69 |
| Volume | 1.16M |
| Average volume | 3.06M |
| Previous close | $4.03 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.